Brief: Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer
10/04/2025 14:44
April 10 (Reuters) - Daxor Corp DXR.O: DAXOR CORPORATION SUBMITS 510(K) TO FDA FOR NEXT-GENERATION BLOOD VOLUME ANALYZER Source text: ID:nGNX6G4m6y Further company coverage: DXR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Daxor
See all newsNASDAQ RESUMED AT 02:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:58 PM
Brief: Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology
Brief: Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer
Brief: Daxor Corporation Streamlines Regulatory Strategy For Groundbreaking Diagnostic Device